Detalles de la búsqueda
1.
The effect of neighborhood socioeconomic disadvantage on smoking status, quit attempts, and receipt of cessation support among adults with cancer: Results from nine ECOG-ACRIN Cancer Research Group trials.
Cancer
; 130(3): 439-452, 2024 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37795845
2.
Is autologous transplant in relapsed DLBCL patients achieving only a PET+ PR appropriate in the CAR T-cell era?
Blood
; 137(10): 1416-1423, 2021 03 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33120429
3.
Outcomes of limited stage primary bone diffuse large B-cell lymphoma in the rituximab era: a multicenter, retrospective study.
Haematologica
; 2023 Oct 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-37855051
4.
Impact of conditioning regimen intensity on the outcomes of peripheral T-cell lymphoma, anaplastic large cell lymphoma and angioimmunoblastic T-cell lymphoma patients undergoing allogeneic transplant.
Br J Haematol
; 197(2): 212-222, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35106754
5.
Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study.
Lancet
; 397(10277): 892-901, 2021 03 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33676628
6.
Long-term outcomes and predictors of early response, late relapse, and survival for patients treated with bispecific LV20.19 CAR T-cells.
Am J Hematol
; 97(12): 1580-1588, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36068950
7.
Intensive induction regimens after deferring initial therapy for mantle cell lymphoma are not associated with improved survival.
Eur J Haematol
; 107(3): 301-310, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-33973276
8.
Multi-center analysis of practice patterns and outcomes of younger and older patients with mantle cell lymphoma in the rituximab era.
Am J Hematol
; 96(11): 1374-1384, 2021 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34324220
9.
Cellular Immunotherapy for Refractory Diffuse Large B Cell Lymphoma in the Chimeric Antigen Receptor-Engineered T Cell Era: Still a Role for Allogeneic Transplantation?
Biol Blood Marrow Transplant
; 26(4): e77-e85, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31917272
10.
Higher Total Body Irradiation Dose Intensity in Fludarabine/TBI-Based Reduced-Intensity Conditioning Regimen Is Associated with Inferior Survival in Non-Hodgkin Lymphoma Patients Undergoing Allogeneic Transplantation.
Biol Blood Marrow Transplant
; 26(6): 1099-1105, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32165327
11.
Fludarabine/Busulfan Conditioning-Based Allogeneic Hematopoietic Cell Transplantation for Myelofibrosis: Role of Ruxolitinib in Improving Survival Outcomes.
Biol Blood Marrow Transplant
; 26(5): 893-901, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31982543
12.
Ixazomib for Chronic Graft-versus-Host Disease Prophylaxis following Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 26(10): 1876-1885, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32653622
13.
Outcomes of rituximab-BEAM versus BEAM conditioning regimen in patients with diffuse large B cell lymphoma undergoing autologous transplantation.
Cancer
; 126(10): 2279-2287, 2020 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32049359
14.
Impact of type of reduced-intensity conditioning regimen on the outcomes of allogeneic haematopoietic cell transplantation in classical Hodgkin lymphoma.
Br J Haematol
; 190(4): 573-582, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32314807
15.
Impact of Obesity on Clinical Outcomes of Elderly Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myeloid Malignancies.
Biol Blood Marrow Transplant
; 25(1): e33-e38, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30244105
16.
Lower Graft-versus-Host Disease and Relapse Risk in Post-Transplant Cyclophosphamide-Based Haploidentical versus Matched Sibling Donor Reduced-Intensity Conditioning Transplant for Hodgkin Lymphoma.
Biol Blood Marrow Transplant
; 25(9): 1859-1868, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31132455
17.
Contemporary Outcomes for Advanced-Stage Classical Hodgkin Lymphoma in the U.S.: Analysis of Surveillance, Epidemiology, and End Results Database.
Oncologist
; 24(11): 1488-1495, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31467178
18.
PD-1 blockade for relapsed lymphoma post-allogeneic hematopoietic cell transplant: high response rate but frequent GVHD.
Blood
; 130(2): 221-228, 2017 07 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-28468799
19.
A phase II study of interrupted and continuous dose lenalidomide in relapsed/refractory Hodgkin lymphoma.
Haematologica
; 109(3): 953-957, 2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37706336
20.
Measurement of circulating tumor DNA to guide management of patients with lymphoma.
Clin Adv Hematol Oncol
; 17(9): 509-517, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31549972